An src/yes-related novel gene named syn (SYN in human gene nomenclature) has been identified in the human genome on chromosome 6 and characterized by molecular cloning. Nucleotide sequence analysis of cDNA clones showed that the c-syn gene could encode a protein-tyrosine kinase that is very similar in primary structure to the v-yes and human c-src proteins. A 2.8-kilobase transcript of the c-syn gene, which differs in size from those of the c-yes, c-src, and c-fgr genes, was observed in various cell types. These results show that syn is a new member of the tyrosine kinase oncogene family.
For example, c-erbB (ERBB)* (5) and c-fms (FMS)* (6) genes encode the epidermal growth factor receptor and mononuclear phagocyte growth factor (CSF-1) receptor, respectively. Thus, at least several protooncogenes of the tyrosine kinase family are involved in the regulation of normal cell growth, and subversion of the protooncogene expression by retroviral induction or possibly by mutation mediates abnormal cell growth leading to neoplastic transformation. However, the function of "nonreceptor"-type protooncogenes of the tyrosine kinase family, such as the c-src (SRC)O gene is unknown. We previously cloned the human c-yes-i (YESI)t, c-yes-2 (YES2)t (pseudogene of c-yes-i), and c-fgrt genes, which are localized on the human chromosomes 18q21.3 (7, 8) , 6 (7) , and lp36.1-36.2 (9, 10), respectively. Besides these genes, we identified an src/yes-related novel gene (syn)t in the human genome. Here we show the molecular cloning and characterization of the c-syn gene.
MATERIALS ANI) METHODS
Cells and Tissues. A431 cells, UCVA cells (11) , and human embryo fibroblasts were maintained in Dulbecco's modified Eagle's medium with 10% fetal calf serum. K562 cells, IM9 cells, and FL18 cells (12) were maintained in RPMI 1640 medium with 10% fetal calf serum.
Isolation of Clones. A human genomic library from placental DNA and a cDNA library from human embryo fibroblasts were constructed by using phage X Charon 4A and XgtlO, respectively, as vectors (13, 14) . Screening of the genomic library was as described (9) . The cDNA library (3.7 x 10O plaques) was screened with a 32P-labeled c-syn-specific probe derived from the c-syn genomic clone (nick-translated to a specific activity of 2 x 108 cpm/,tg of DNA) under stringent conditions (15) .
Nucleotide Sequence Analysis. The nucleotide sequence was determined by the dideoxy chain-termination method (16) with modification (17, 18) in conjunction with plasmid pUC19.
Blot-Hybridization Analysis of DNA and RNA. High molecular weight DNAs were digested with restriction endonucleases HindIII under the conditions recommended by suppliers (Takara Shuzo Co., Kyoto, Japan) and fractionated by electrophoresis in 0.9% agarose gels. The fragments were subjected to Southern blot hybridization with the c-syn probe or with a v-myb probe as described (15) . Poly(A)+ RNAs were electrophoresed in 1% agarose gel containing 2.2 M formaldehyde and were subjected to blot hybridization as described (15) . The DNA probes were labeled with 32P by nick-translation to a specific activity of 2 x 108 cpm/,ug of DNA.
Karyotype Analysis of Human-Mouse Hybrid Cells. Somatic cell hybrids were generated by fusion (19) of human embryo fibroblasts with mouse FM3A cells. The human chromosome content was determined by the method of differential staining of human and mouse chromosomes (20) .
RESULTS AND DISCUSSION
Identification of a yes-Related Gene. With a 1.5-kilobasepair (kbp) v-yes DNA segment (7) as a screening probe, we isolated 26 independent clones from a human gene library (9) . The restriction maps of 3 of them were distinct from those of the genomic clones representing the c-yes-i, c-yes-2, c-fgr, and c-src genes (refs. 9 and 21; unpublished data), which suggested that these 3 clones represent a novel v-yes-related gene. We named this the syn gene (src/yes-related novel protooncogene). By analyzing the nucleotide sequence of the cloned insert that hybridized with the v-yes probe, one putative exon flanked by the splicing consensus sequence (22) (24) c-src (exon 8), human c-fgr (9) , and human c-yes-i (unpublished data) genes. Thus, the c-syn gene is evolutionarily close to the c-src, c-fgr, and c-yes genes, with which it shows a common intron-exon organization that differs from those of other members of the c-src family such as c-abl (ABL)* (25) , c-fps* (26) , c-raf(RAF)/milt (27) , and c-erbB-2 (ERBB2) (15) .
Allocation of the c-syn Gene to Human Chromosome 6. The chromosomal location of the c-syn gene was determined by Southern blot analysis of 14 human-mouse hybrid cells with 32P-labeled Kpn I-Dra I (KD) fragment generated from the c-syn genomic clone ( Fig. LA and Table 1 ). This probe contains the whole exon described above and hybridized with an 8-kbp HindIII fragment of the human c-syn gene (Fig. LA) . The probe also cross-hybridized with the 7-kbp fragment of the mouse c-syn gene. The data showed that the c-syn gene is located on human chromosome 6, while the c-yes-i, c-src, and c-fgr genes have been localized on 18q21.3 (7, 8) , 20q12-13 (28) , and lp36.1-36.2 (9, 10), respectively. The chromosome localization of the c-syn gene was confirmed by probing the DNAs of hybrid cells with the v-myb DNA, whose human homolog (MYB)* has been assigned to chromosome 6. The v-myb probe reacted with a 7-kbp HindIII fragment of the human c-myb gene and with 3.2-kbp and 2.5-kbp fragments of the mouse c-myb gene (Fig. 1B) . We previously mapped a v-yes-related pseudogene, c-yes-2, on chromosome 6 (7). However, the c-syn gene is distinct from the c-yes-2 gene because it has different nucleotide sequences in corresponding regions. For example, the nucleotide sequence of the c-yes-2 gene that corresponds to the sequence 1369-1398 of c-syn (Fig. 2B ) is TGG GAA ATC CCT TGA TAA TCT TTG CGA CTA. A deletion of the distal half of chromosome 6q is often observed in acute lymphoblastic leukemia (29) . Translocation between chromosomes 6 and 14 is associated with ovarian papillary adenocarcinomas (29) . The precise location of the c-syn gene and further analysis of the c-syn locus in these tumors are required.
cDNA Cloning and Molecular Characterization of c-syn. RNA blot analysis with the 32P-labeled KD fragment revealed a 2.8-kb c-syn mRNA in human embryo fibroblasts (see below). A cDNA library constructed from mRNA from human embryo fibroblasts was screened with the KD probe. Among four positive clones, XSN-2 had the longest insert of nearly full length (2.6 kbp), consisting of one EcoRI insert ( Fig. 2A) . The 2.6-kbp EcoRI insert was recloned (pSN-2) into plasmid vector pUC19 and then subjected to nucleotide sequence analysis. The longest open reading frame starting with a methionine codon at position 580 in the nucleotide sequence encodes a 537-amino acid polypeptide that includes the 59-amino acid residues of the putative exon described above (positions 289-347, Fig. 2B ). Although the flanking nucleotides of the predicted initiation codon ATG do not show a perfect match with Kozak's consensus sequence (30) , this codon seems to be the initiation codon because a stop codon (TAG) is found in the frame, immediately upstream in the 5' untranslated region. The of the c-syn sequence with that of chicken c-src (23) , human domain of src as well as of yes and fgr has been shown to c-fgr (9) , and v-yes (31) . The homology is prominent in the encode protein with protein-tyrosine kinase activity, the syn amino acid sequence between position 83 and 537 of syn: 80o protein is also expected to specify the kinase activity. This (syn/yes), 77% (syn/src), and 77% (syn/fgr). Since this conclusion is supported by the fact that a lysine residue at Proc. Natl, Acad. Sci. USA 83 (1986) (31) , and human c-fgr (9) . Identical amino acids in the putative c-syn protein and other proteins are boxed. Asterisks indicate residues that are thought to be associated with nucleotide binding. The closed triangle indicates a tyrosine expected to be autophosphorylated. Ser-12 of pp6Osrc, which is phosphorylated by protein kinase C, and the corresponding amino acid residue, Thr-12, of c-syn are indicated by arrows. Amino acids of the four proteins are numbered on the left. The extreme 5' sequence of the human c-fgr protein is not available. position 299, suggested to be involved in ATP binding (32) , is conserved in the syn protein sequence, as is a consensus sequence Gly-Xaa-Gly-Xaa-Xaa-Gly (33) at position 278-283 (Fig. 3) . Furthermore, the Tyr-416 autophosphorylation site of pp60src (34) is also conserved in the putative syn protein (tyrosine at position 420). The amino acid homology between syn and yes in the amino-terminal moiety (positions 1-82) is extremely low (29%). Homology between syn and src is also low (23%) at this region. The low homology of the aminoterminal portion of the syn protein to those ofrelated proteins suggests that the amino-terminal sequences specify the specialized functions of these proteins. The amino acid at position 81 of chicken c-src (equivalent to position 82 of c-syn) precisely coincides with the splicing site in the chicken c-src gene (23) . The splicing mechanism could have been involved in a gene-shuffling process that may have played a role in the generation of src/yes-related genes with distinct functions. Threonine at position 12 is flanked by lysine residues and may well be phosphorylated by protein kinase C as reported for Ser-12 of pp60srC (35) . However, it should be mentioned that Thr-12 of syn is embedded in the more acidic environment than is Ser-12 of the latter.
Expression of the c-syn Gene. Poly(A)+ RNA was prepared from human placenta, adenocarcinoma cells of the human pancreas UCVA, human embryo fibroblasts, chronic myelogenous leukemia cells K562, human lymphoid cells IM-9, epidermoid carcinoma cells A431, and human follicular lymphoma cells FL18. Blot-hybridization analysis of these RNAs with the KD probe revealed the expression of the 2.8-kb syn mRNA at various levels in these cells, although it was not detected in UCVA cells (Fig. 4A) . The size of the syn transcript differs from those of the c-yes (7), c-src (36) , and c-fgr (9) mRNAs. In the same filter, the c-fgr mRNA was detected exclusively in IM-9 (Fig. 4C) . Only a low level of the c-fgr transcript was observed in placenta (9) . As IM-9 cells have been immortalized with the infection by Epstein-Barr virus, our observation is consistent with the finding that c-fgr mRNA is induced by Epstein-Barr virus infection (37) . Transcription of the c-yes gene was relatively high in both A431 and UCVA cells, in which the expression of the epidermal growth receptor at the cell surface is high and was undetectable in FL18 cells. (Fig. 4B) (ref. 7) . Comparison of the hybridization blots of these mRNAs suggests that the expression of these related genes is distinctly regulated in each of the cells examined. Relatively high expression of the c-syn and c-fgr mRNAs in IM9 deserves further analysis.
Implications. In this report, we showed identification of a yes-related gene that could encode a protein-tyrosine kinase. Besides syn, we have recently obtained cDNA clones carrying distinct yes-related sequences from chicken and human cDNA libraries (unpublished data). These genes also can encode proteins with protein-tyrosine kinase activity. In addition, a lymphocyte-specific protein-tyrosine kinase gene lskT/tck recently has been cloned molecularly and shown to (5 ,ug) were subjected to blot hybridization with 32P-labeled KD DNA probe (A), c-yes probe (unpublished data) (B), and c-fgr probe (9) (C) under stringent conditions as described (15 be highly related to the yes gene (38, 39) . We do not know how the expression of these "similar but distinct" genes is regulated. Protein-tyrosine kinases are rare enzymes and have been believed to have a regulatory function in normal cells. An idea that stems from the findings of higher expression of the c-src gene in neural tissues (40, 41) is that the "nonreceptor"-type protooncogene of the kinase family may be involved in a variety of functions specific to differentiated cells. As far as we examined, expression ofthe c-fgr gene was specific in IM9 human lymphoid cells. In contrast, c-yes and c-syn expression of mRNA was observed in various types of cells, although the modes of expression of these genes differ from each other. More extensive analysis of these similar but distinct genes, including in situ analyses of mRNAs and proteins, is required to determine whether the proteintyrosine kinase activities of these products are specific to certain cell lineage or whether it plays a more general role in cell growth.
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